Pernix Therapeutics Holdings Inc (PTX.OQ)
23 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|72||2016||Chairman of the Board, Chief Executive Officer|
|2018||Senior Vice President, Chief Business Officer and Principal Financial Officer|
|59||2017||Senior Vice President, Chief Compliance Officer, General Counsel|
|49||2017||Interim Vice President - Finance, Principal Accounting Officer, Corporate Controller|
|68||2018||Lead Independent Director|
- BRIEF-Pernix Therapeutics Announces Participation In Lead Bid Worldwide Rights Of Contrave
- BRIEF-Pernix Therapeutics Reports Q4 Loss Per Share $2.78
- BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis
- BRIEF-Pernix Therapeutics Will Reduce Workforce By 41 Employees
- BRIEF-Pernix Therapeutics files for mixed shelf offering of up to $150 mln